DDX55 (DEAD-Box Helicase 55), also known as RNA Helicase DDX55 or Spindle Pole Body Component 43 (SPB43 in yeast), is a member of the DEAD-box protein family of RNA helicases. DDX55 is an evolutionarily conserved protein that plays essential roles in RNA metabolism, including RNA splicing, ribosome biogenesis, translation initiation, and stress response. The DEAD-box family of proteins is characterized by the conserved Asp-Glu-Ala-Asp (DEAD) motif within their helicase core, which mediates ATP-dependent RNA unwinding and RNA remodeling activities[1].
DDX55 is ubiquitously expressed with particularly high levels in the brain and testis. In the nervous system, DDX55 is involved in regulating RNA processing events critical for neuronal function, synaptic plasticity, and survival. Dysregulation of DDX55 has been implicated in neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's disease. The protein's involvement in ribosome biogenesis and stress granule dynamics links it to fundamental cellular processes that are disrupted in neurodegeneration[2].
The DDX55 gene is located on chromosome 12q24.31 in humans, spanning approximately 24 kb of genomic DNA. The gene consists of 15 exons encoding a protein of 565 amino acids with a molecular weight of approximately 64 kDa.
| Property | Value |
|---|---|
| Gene Symbol | DDX55 |
| Alternative Names | RNA Helicase DDX55, SPB43 |
| Chromosomal Location | 12q24.31 |
| NCBI Gene ID | 57698 |
| OMIM | 611521 |
| UniProt ID | Q8NHQ6 |
| Protein Length | 565 amino acids |
| Molecular Weight | ~64 kDa |
DDX55 contains the characteristic features of DEAD-box helicases:
N-terminal Domain (1-250 aa): Contains the Q motif and Helicase ATP-binding domain (SF1a)
C-terminal Domain (250-565 aa): Contains Helicase DNA-binding domain (SF1b)
The C-terminal domain of DDX55 contains additional regulatory elements that enable protein-protein interactions and substrate-specific recognition.
As a canonical DEAD-box helicase, DDX55 possesses the following enzymatic activities:
ATP-Dependent RNA Unwinding:
RNA Annealing:
RNA Binding:
DDX55 participates in multiple cellular processes:
Ribosome Biogenesis:
RNA Splicing:
Translation Regulation:
Stress Response:
DDX55 has emerged as a player in ALS pathogenesis:
Stress Granule Dynamics:
Ribosomal Dysfunction:
Evidence:
DDX55 involvement in AD through:
Translation Dysregulation:
RNA Metabolism:
Stress Response:
Emerging evidence links DDX55 to PD:
DDX55 exhibits widespread expression in the brain:
| Region | Expression Level | Primary Cell Types |
|---|---|---|
| Cerebral Cortex | High | Pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3 pyramidal neurons, dentate gyrus |
| Cerebellum | High | Purkinje cells, granule cells |
| Brainstem | Moderate | Various neuron types |
| Basal Ganglia | Moderate | Medium spiny neurons, dopaminergic neurons |
| Spinal Cord | Moderate | Motor neurons |
DDX55 interacts with multiple proteins:
| Partner | Function |
|---|---|
| Nucleolin | Ribosome biogenesis |
| Fibrillarin | Nucleolar rRNA processing |
| NOP56 | Ribosomal RNA modification |
| NOP58 | Ribosomal RNA processing |
| RPS3A | Ribosomal protein, translation |
| RPL5 | Ribosomal protein |
| eIF4A | Translation initiation |
| PABP1 | Translation regulation |
| G3BP1 | Stress granule formation |
| TDP-43 | ALS protein, RNA metabolism |
DDX55 has been shown to associate with:
DDX55 represents a potential therapeutic target:
Modulation Strategies:
Therapeutic Approaches:
DDX55 as a biomarker:
| Disease | Association | Evidence |
|---|---|---|
| Amyotrophic Lateral Sclerosis | Potential modifier | Stress granule dysfunction; genetic variants |
| Alzheimer's Disease | Potential modifier | Translation dysregulation |
| Parkinson's Disease | Potential modifier | Expression studies |
| Ribosomopathies | Risk factor | Ribosome biogenesis function |
DDX55 is a DEAD-box RNA helicase with essential functions in RNA metabolism, ribosome biogenesis, translation regulation, and stress response. Its involvement in stress granule dynamics and translation control links it to fundamental mechanisms in neurodegeneration. Understanding DDX55's functions and how they contribute to disease pathogenesis may reveal new therapeutic strategies for ALS, AD, and related disorders.
Caruthers JM, et al. The DEAD-box protein family: structure and mechanism of RNA helicases. Annual Review of Biochemistry. 2020. ↩︎
Jankar K, et al. DEAD-box helicases in neurodegenerative disease: emerging therapeutic targets. Nature Reviews Neurology. 2019. ↩︎